Symbol
LYEL on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001
Latest Disclosed Shares Owned
1,040,964 shares
Security Ownership %
5.6%

Gates Frontier, LLC ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)

01 Aug 2025 - Gates Frontier, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,040,964 shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL). This represents 5.6% ownership of the company. This is the first filing by Gates Frontier, LLC disclosing ownership of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).